Adolescents and opioid-related outcomes amidst the COVID-19 pandemic

J Addict Dis. 2022 Jan-Mar;40(1):126-130. doi: 10.1080/10550887.2021.1916420. Epub 2021 May 6.

Abstract

Morbidity and mortality attributable to opioid use and misuse among adolescents and young adults are evident. Although recent trend data suggest a decrease in both opioid misuse and opioid use disorder among adolescents and young adults in the last few years, overdose cases continue to rise. The opioid epidemic among this population is complex and has a different profile compared to adults, with family facilitating exposure to opioids more often than other sources. Additionally, despite recommendations by experts to initiate medications for opioid use disorder, few initiate treatment. The recent COVID-19 pandemic has impacted many facets of daily life and its effects on the opioid crisis are largely unknown. Stay-at-home mandates resulting in online schooling and limited social interaction has had deleterious consequences for adolescents, especially their mental health. This viewpoint attempts to explore the effects of the pandemic on the opioid crisis in this vulnerable population.

Keywords: Adolescents; COVID-19; opioids.

MeSH terms

  • Adolescent
  • Analgesics, Opioid / adverse effects
  • COVID-19*
  • Drug Overdose* / drug therapy
  • Humans
  • Opioid-Related Disorders* / drug therapy
  • Opioid-Related Disorders* / epidemiology
  • Pandemics
  • SARS-CoV-2
  • Young Adult

Substances

  • Analgesics, Opioid